BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31651348)

  • 21. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
    Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
    Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
    Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. USP17 is upregulated in osteosarcoma and promotes cell proliferation, metastasis, and epithelial-mesenchymal transition through stabilizing SMAD4.
    Song C; Liu W; Li J
    Tumour Biol; 2017 Jul; 39(7):1010428317717138. PubMed ID: 28670958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
    Zhu J; Liu F; Wu Q; Liu X
    Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
    Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
    Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
    Zeng SX; Cai QC; Guo CH; Zhi LQ; Dai X; Zhang DF; Ma W
    Oncol Rep; 2017 Sep; 38(3):1645-1654. PubMed ID: 28731167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.
    Habel N; Stefanovska B; Carène D; Patiño-Garcia A; Lecanda F; Fromigué O
    BMC Cancer; 2019 Jan; 19(1):62. PubMed ID: 30642298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
    Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
    Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.
    Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J
    Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1.
    Liu Y; Zhang J; Xing C; Wei S; Guo N; Wang Y
    Cancer Biomark; 2018; 23(2):269-277. PubMed ID: 30103304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
    Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
    Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-363 acts as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2.
    He F; Fang L; Yin Q
    Oncol Rep; 2019 May; 41(5):2729-2738. PubMed ID: 30896877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway.
    Liu ZB; Tang C; Jin X; Liu SH; Pi W
    Cancer Biomark; 2018; 23(4):603-613. PubMed ID: 30452404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
    Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.
    Che J; Yue D; Zhang B; Zhang H; Huo Y; Gao L; Zhen H; Yang Y; Cao B
    Int J Med Sci; 2018; 15(4):339-351. PubMed ID: 29511369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
    Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.